How Medical Professionals Support Biospecimen Procurement?

While being essential for innovative drug discovery, the biospecimen procurement process is complex and not well understood even by some of its key players – the medical and clinical professionals. As our actions are closely reliant on efficient communication with our clinical partners, we prepared this graphical representation highlighting the main topics that appear unclear…

Read More

Discovery, Validation and Use of Cancer Biomarkers — Current Trends and Obstacles

When we speak about the role of biospecimens in the advancement of personalized precision medicine, we can’t avoid the topic of biomarkers. The term biomarker indicates a molecular signature (DNA, RNA, protein, lipid, metabolite) that can be objectively measured. Its levels are an indication of a normal physiological process, an abnormal pathological condition, or a…

Read More

6 Cancer Research Advancements Reliant on Human Biospecimens

March 16, 2021 Over the last two decades, oncology research has achieved outstanding results in the way we understand and approach the multifaceted nature of cancer. From immuno-oncology at the forefront to targeted therapies and biomarkers identification, novel therapeutic multiplicity is impressive. Despite their diversification, these therapies have few crucial commonalities: they are targeted, personalized,…

Read More